Asset Management
Compare Stocks
4 / 10Stock Comparison
CRBG vs BLK vs IVZ vs TROW
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
Asset Management
Asset Management
CRBG vs BLK vs IVZ vs TROW — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Asset Management | Asset Management | Asset Management | Asset Management |
| Market Cap | $12.47B | $168.28B | $12.26B | $22.92B |
| Revenue (TTM) | $2.89B | $20.41B | $6.38B | $7.31B |
| Net Income (TTM) | $245M | $6.10B | $-243M | $2.09B |
| Gross Margin | 80.9% | 49.4% | 43.2% | 62.7% |
| Operating Margin | -18.7% | 37.1% | -10.9% | 29.9% |
| Forward P/E | 5.6x | 20.4x | 10.7x | 11.2x |
| Total Debt | $10.91B | $14.22B | $10.12B | $860M |
| Cash & Equiv. | $447M | $12.76B | $1.98B | $3.38B |
CRBG vs BLK vs IVZ vs TROW — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 22 | May 26 | Return |
|---|---|---|---|
| Corebridge Financia… (CRBG) | 100 | 138.7 | +38.7% |
| BlackRock, Inc. (BLK) | 100 | 197.1 | +97.1% |
| Invesco Ltd. (IVZ) | 100 | 201.4 | +101.4% |
| T. Rowe Price Group… (TROW) | 100 | 100.3 | +0.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CRBG vs BLK vs IVZ vs TROW
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CRBG is the #2 pick in this set and the best alternative if value is your priority.
- Lower P/E (5.6x vs 11.2x)
BLK carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 14.3%, EPS growth 15.1%
- 250.5% 10Y total return vs CRBG's 57.3%
- 14.3% NII/revenue growth vs TROW's 3.1%
- Efficiency ratio 0.1% vs CRBG's 1.0% (lower = leaner)
IVZ is the clearest fit if your priority is momentum.
- +92.7% vs CRBG's -9.6%
TROW is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 3 yrs, beta 1.16, yield 4.8%
- Lower volatility, beta 1.16, Low D/E 7.1%, current ratio 73.08x
- Beta 1.16, yield 4.8%, current ratio 73.08x
- NIM 3.4% vs BLK's 0.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 14.3% NII/revenue growth vs TROW's 3.1% | |
| Value | Lower P/E (5.6x vs 11.2x) | |
| Quality / Margins | Efficiency ratio 0.1% vs CRBG's 1.0% (lower = leaner) | |
| Stability / Safety | Beta 1.16 vs IVZ's 1.67, lower leverage | |
| Dividends | 1.9% yield, 15-year raise streak, vs TROW's 4.8% | |
| Momentum (1Y) | +92.7% vs CRBG's -9.6% | |
| Efficiency (ROA) | Efficiency ratio 0.1% vs CRBG's 1.0% |
CRBG vs BLK vs IVZ vs TROW — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CRBG vs BLK vs IVZ vs TROW — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CRBG leads in 3 of 6 categories
TROW leads 1 • BLK leads 0 • IVZ leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CRBG leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
BLK is the larger business by revenue, generating $20.4B annually — 7.1x CRBG's $2.9B. BLK is the more profitable business, keeping 31.2% of every revenue dollar as net income compared to CRBG's -12.7%.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $2.9B | $20.4B | $6.4B | $7.3B |
| EBITDAEarnings before interest/tax | $1.0B | $8.3B | $1.2B | $2.7B |
| Net IncomeAfter-tax profit | $245M | $6.1B | -$243M | $2.1B |
| Free Cash FlowCash after capex | $1.6B | $3.9B | $1.9B | $2.3B |
| Gross MarginGross profit ÷ Revenue | +80.9% | +49.4% | +43.2% | +62.7% |
| Operating MarginEBIT ÷ Revenue | -18.7% | +37.1% | -10.9% | +29.9% |
| Net MarginNet income ÷ Revenue | -12.7% | +31.2% | -4.4% | +28.5% |
| FCF MarginFCF ÷ Revenue | +70.0% | +23.0% | +22.6% | +20.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +90.8% | -22.7% | +34.2% | +3.7% |
Valuation Metrics
CRBG leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 11.4x trailing earnings, TROW trades at a 56% valuation discount to BLK's 25.8x P/E. On an enterprise value basis, TROW's 7.8x EV/EBITDA is more attractive than CRBG's 1528.8x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $12.5B | $168.3B | $12.3B | $22.9B |
| Enterprise ValueMkt cap + debt − cash | $22.9B | $169.7B | $20.4B | $20.4B |
| Trailing P/EPrice ÷ TTM EPS | -40.16x | 25.82x | -17.24x | 11.39x |
| Forward P/EPrice ÷ next-FY EPS est. | 5.56x | 20.42x | 10.73x | 11.19x |
| PEG RatioP/E ÷ EPS growth rate | — | 3.18x | — | — |
| EV / EBITDAEnterprise value multiple | 1528.81x | 20.95x | 16.62x | 7.78x |
| Price / SalesMarket cap ÷ Revenue | 4.32x | 8.25x | 1.92x | 3.13x |
| Price / BookPrice ÷ Book value/share | 1.05x | 3.33x | 0.96x | 1.96x |
| Price / FCFMarket cap ÷ FCF | 6.17x | 35.80x | 8.51x | 15.50x |
Profitability & Efficiency
TROW leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
TROW delivers a 17.6% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $-2 for IVZ. TROW carries lower financial leverage with a 0.07x debt-to-equity ratio, signaling a more conservative balance sheet compared to CRBG's 0.78x. On the Piotroski fundamental quality scale (0–9), CRBG scores 6/9 vs TROW's 4/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +1.8% | +9.9% | -1.7% | +17.6% |
| ROA (TTM)Return on assets | +0.1% | +3.7% | -0.9% | +14.4% |
| ROICReturn on invested capital | -1.6% | +9.9% | -2.3% | +13.3% |
| ROCEReturn on capital employed | -0.1% | +5.8% | -2.6% | +15.9% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 6 | 6 | 4 |
| Debt / EquityFinancial leverage | 0.78x | 0.29x | 0.78x | 0.07x |
| Net DebtTotal debt minus cash | $10.5B | $1.5B | $8.1B | -$2.5B |
| Cash & Equiv.Liquid assets | $447M | $12.8B | $2.0B | $3.4B |
| Total DebtShort + long-term debt | $10.9B | $14.2B | $10.1B | $860M |
| Interest CoverageEBIT ÷ Interest expense | 1.79x | 9.27x | -6.19x | — |
Total Returns (Dividends Reinvested)
CRBG leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CRBG five years ago would be worth $15,726 today (with dividends reinvested), compared to $6,971 for TROW. Over the past 12 months, IVZ leads with a +92.7% total return vs CRBG's -9.6%. The 3-year compound annual growth rate (CAGR) favors CRBG at 24.0% vs TROW's 4.2% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -9.3% | +0.5% | +3.2% | +1.9% |
| 1-Year ReturnPast 12 months | -9.6% | +19.1% | +92.7% | +19.2% |
| 3-Year ReturnCumulative with dividends | +90.7% | +78.3% | +84.5% | +13.2% |
| 5-Year ReturnCumulative with dividends | +57.3% | +38.0% | +11.6% | -30.3% |
| 10-Year ReturnCumulative with dividends | +57.3% | +250.5% | +24.6% | +95.9% |
| CAGR (3Y)Annualised 3-year return | +24.0% | +21.3% | +22.6% | +4.2% |
Risk & Volatility
Evenly matched — IVZ and TROW each lead in 1 of 2 comparable metrics.
Risk & Volatility
TROW is the less volatile stock with a 1.16 beta — it tends to amplify market swings less than IVZ's 1.67 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IVZ currently trades 93.2% from its 52-week high vs CRBG's 74.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.49x | 1.29x | 1.67x | 1.16x |
| 52-Week HighHighest price in past year | $36.57 | $1219.94 | $29.61 | $118.22 |
| 52-Week LowLowest price in past year | $22.19 | $917.39 | $14.10 | $85.51 |
| % of 52W HighCurrent price vs 52-week peak | +74.7% | +88.9% | +93.2% | +89.1% |
| RSI (14)Momentum oscillator 0–100 | 57.7 | 59.3 | 63.2 | 66.1 |
| Avg Volume (50D)Average daily shares traded | 5.6M | 782K | 5.1M | 2.3M |
Analyst Outlook
Evenly matched — BLK and TROW each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CRBG as "Buy", BLK as "Buy", IVZ as "Hold", TROW as "Hold". Consensus price targets imply 21.6% upside for CRBG (target: $33) vs -3.9% for TROW (target: $101). For income investors, TROW offers the higher dividend yield at 4.85% vs BLK's 1.89%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | $33.20 | $1311.78 | $29.72 | $101.20 |
| # AnalystsCovering analysts | 18 | 33 | 28 | 38 |
| Dividend YieldAnnual dividend ÷ price | +3.5% | +1.9% | +3.0% | +4.8% |
| Dividend StreakConsecutive years of raises | 1 | 15 | 4 | 3 |
| Dividend / ShareAnnual DPS | $0.95 | $20.46 | $0.83 | $5.11 |
| Buyback YieldShare repurchases ÷ mkt cap | +17.0% | +1.1% | +15.2% | +2.7% |
CRBG leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). TROW leads in 1 (Profitability & Efficiency). 2 tied.
CRBG vs BLK vs IVZ vs TROW: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CRBG or BLK or IVZ or TROW a better buy right now?
For growth investors, BlackRock, Inc.
(BLK) is the stronger pick with 14. 3% revenue growth year-over-year, versus 3. 1% for T. Rowe Price Group, Inc. (TROW). T. Rowe Price Group, Inc. (TROW) offers the better valuation at 11. 4x trailing P/E (11. 2x forward), making it the more compelling value choice. Analysts rate Corebridge Financial, Inc. (CRBG) a "Buy" — based on 18 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CRBG or BLK or IVZ or TROW?
On trailing P/E, T.
Rowe Price Group, Inc. (TROW) is the cheapest at 11. 4x versus BlackRock, Inc. at 25. 8x. On forward P/E, Corebridge Financial, Inc. is actually cheaper at 5. 6x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — CRBG or BLK or IVZ or TROW?
Over the past 5 years, Corebridge Financial, Inc.
(CRBG) delivered a total return of +57. 3%, compared to -30. 3% for T. Rowe Price Group, Inc. (TROW). Over 10 years, the gap is even starker: BLK returned +250. 5% versus IVZ's +24. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CRBG or BLK or IVZ or TROW?
By beta (market sensitivity over 5 years), T.
Rowe Price Group, Inc. (TROW) is the lower-risk stock at 1. 16β versus Invesco Ltd. 's 1. 67β — meaning IVZ is approximately 43% more volatile than TROW relative to the S&P 500. On balance sheet safety, T. Rowe Price Group, Inc. (TROW) carries a lower debt/equity ratio of 7% versus 78% for Corebridge Financial, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CRBG or BLK or IVZ or TROW?
By revenue growth (latest reported year), BlackRock, Inc.
(BLK) is pulling ahead at 14. 3% versus 3. 1% for T. Rowe Price Group, Inc. (TROW). On earnings-per-share growth, the picture is similar: BlackRock, Inc. grew EPS 15. 1% year-over-year, compared to -235. 6% for Invesco Ltd.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CRBG or BLK or IVZ or TROW?
BlackRock, Inc.
(BLK) is the more profitable company, earning 31. 2% net margin versus -12. 7% for Corebridge Financial, Inc. — meaning it keeps 31. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BLK leads at 37. 1% versus -18. 7% for CRBG. At the gross margin level — before operating expenses — CRBG leads at 80. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CRBG or BLK or IVZ or TROW more undervalued right now?
On forward earnings alone, Corebridge Financial, Inc.
(CRBG) trades at 5. 6x forward P/E versus 20. 4x for BlackRock, Inc. — 14. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CRBG: 21. 6% to $33. 20.
08Which pays a better dividend — CRBG or BLK or IVZ or TROW?
All stocks in this comparison pay dividends.
T. Rowe Price Group, Inc. (TROW) offers the highest yield at 4. 8%, versus 1. 9% for BlackRock, Inc. (BLK).
09Is CRBG or BLK or IVZ or TROW better for a retirement portfolio?
For long-horizon retirement investors, T.
Rowe Price Group, Inc. (TROW) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 16), 4. 8% yield). Invesco Ltd. (IVZ) carries a higher beta of 1. 67 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (TROW: +95. 9%, IVZ: +24. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CRBG and BLK and IVZ and TROW?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CRBG is a mid-cap income-oriented stock; BLK is a mid-cap quality compounder stock; IVZ is a mid-cap income-oriented stock; TROW is a mid-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.